drugset / Trial / NCT00800345
Phase I Trial of Oral Metronomic Topotecan and Oral Pazopanib to Treat Recurrent/Persistent Gynecologic Tumors
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase 1, dose-escalation study in female patients with recurrent or persistent gynecologic tumors.
Timeline
- Start
- 2009-04
- Primary completion
- 2015-06
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pazopanib | Small molecule | — | Oral |
| Subject | Topotecan | Small molecule | — | Oral |